Industry News

Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031

By HospiMedica International staff writers
22 Jun 2022

Image: The global minimally invasive surgery (MIS) market is forecasted to surpass USD 325 billion by 2031 (Photo courtesy of Pexels)

Technological advancements in robotics, image guidance systems, and equipment such as laparoscopic instruments and sutures continue to enhance the benefits of minimally invasive surgery (MIS) techniques. The adoption of laparoscopic techniques, particularly in general surgery, has been one of the key drivers of the growth in the MIS market. The surge in laparoscopic procedures performed globally over the past few decades has generated massive revenues for the market players. Medtech companies have also earned significant revenues from the sales of surgical equipment made of innovative materials, such as in handheld equipment. Moreover, a rise in the number of MIS procedures in cardiology, particularly for transcatheter aortic valve replacement (TAVR), has offered growth opportunities for the key players in the MIS market. The growing adoption of robot-assisted surgeries in multiple specialties has allowed companies to increase their share in the minimally invasive surgery market. The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.


These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company.


Continuous innovation in robotic surgery systems has contributed significantly to the growth of the MIS market. Increasing adoption of and preference for robotics-assisted surgical systems, particularly in complex surgeries, has driven the revenue growth of the market players. Over the past few years, there has been rapid commercialization of surgical robots in the MIS market due to their adoption in the fields of orthopedic and neurology. There has been increased preference for MIS among surgeons as well as patients in orthopedic procedures over the past few decades. The demand for MIS for orthopedic procedures, including knee replacement, continues to grow, thereby expanding the MIS market.


The adoption of cutting-edge 3D visualization technology and innovations in surgical instruments and sutures has opened up huge growth opportunities for the players in the MIS market. Medtech and healthcare IT companies have been increasing their R&D activities and investments in surgical instruments to capitalize on the growth in the MIS market. Growing awareness among the elderly population about the benefits of MIS such as short hospital stay and rapid post-surgery recovery is propelling the demand in the MIS market. Moreover, increased access to medical reimbursements for chronic diseases is contributing to the demand for MIS in hospitals.


Additionally, the remarkable pace of adoption of laparoscopic procedures in various specialties is driving constant advancements in MIS-associated technologies. As the application of laparoscopic instruments continues to grow in the near future, growing awareness of the advantages of surgical robots over conventional laparoscopy, and new-age instruments in the MIS market, such as the highly popular single-incision laparoscopic surgery, are likely to open up new opportunities for the market players.


Geographically, Europe held a substantial share of the global MIS market in 2020 mainly due to a rise in the region’s elderly population and is anticipated to hold a significant share of the global MIS market during the forecast period. Latin America is expected to emerge as an extremely lucrative MIS market and register a high CAGR during 2022-2031, as the high prevalence of chronic illness in the region will propel the demand for MIS.


Related Links:
Transparency Market Research 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

16 Aug 2022
BD and Accelerate Diagnostics Collaborate to Offer Rapid Antimicrobial Identification and Susceptibility Diagnostics
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) and Accelerate Diagnostics, Inc. (Tucson, AZ, USA) have entered into a worldwide commercial collaboration agreement where BD will offer Accelerate's rapid testing solution for antibiotic resistance and susceptibility offering results in hours, versus one to two days with some traditional laboratory methods.
Read More
05 Aug 2022
Bio-Rad Acquires Curiosity Diagnostics from Scope Fluidics
Bio-Rad Laboratories (Hercules, CA, USA) has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (Warsaw, Poland) for a total consideration of up to USD 170 million, consisting of approximately USD 100 million in cash, and up to USD 70 million in future milestone payments.
Read More
04 Aug 2022
Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure
The global capsule endoscopy system market is expanding at a rapid pace due to the rising demand for the procedure using minimally invasive diagnostic techniques, increase in the introduction of technologically advanced capsules, growth in the geriatric population, and rising prevalence of cancer around the world.
Read More
02 Aug 2022
PerkinElmer Divests Other Businesses to Focus on Life Sciences and Diagnostics
PerkinElmer, Inc. (Waltham, MA; USA) has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital (New York, NY, USA) for total consideration of USD 2.45 billion in cash.
Read More
31 Jul 2022
Labcorp to Spin Off Clinical Development Business
LabCorp Diagnostics (Burlington, NC, USA) has announced that its board of directors has authorized the company to pursue a spin-off of its wholly owned Clinical Development business to shareholders through a tax-free transaction.
Read More
31 Jul 2022
IFCC Celebrates 70 Years of Advancing Science of Laboratory Medicine and In Vitro Diagnostics
The IFCC is celebrating 70 years (1952 – 2022) of enormous achievements that have been extraordinary and impressive, contributing to its mission of “Advancing excellence in laboratory medicine for better healthcare worldwide”.
Read More
27 Jul 2022
Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand
Informa Markets (London, UK), in partnership with Impact Muang Thong Thani (Nonthaburi, Thailand), have confirmed that Medlab Asia and Asia Health will take place in Thailand for the first time when the co-located events return live and in-person at the Impact Exhibition Center, Bangkok, from 19-21 October 2022.
Read More
25 Jul 2022
Registration Opens for RSNA 2022
Registration is now open for the Radiological Society of North America’s (RSNA, Oak Brook, IL, USA) 108th Scientific Assembly and Annual Meeting to be held at McCormick Place Chicago, Nov. 27 – Dec. 1, 2022.
Read More
25 Jul 2022
Bioperfectus and ELITechGroup Collaborate for Monkeypox Virus Testing Across Europe
Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) and ELITechGroup S.p.A. (Puteaux, France) have entered into a strategic partnership for monkeypox virus testing across Europe.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions